I’m nonplussed. Like I totally lack plus. Plus-free zone here. Not a single plus was given this day.
Via Neyer, comes Mike Silva’s interview with John Rocker from the other night in which the pumped up fireballer with anger issues — shockingly — admitted to using steroids during his career. Here’s Silva:
I was surprised by his admission to taking steroids, so I asked him again if he was taking some sort of PED in 1999. “Yeah, of course I was. I mean who wasn’t? Let’s be honest here, who wasn’t?”
And there was a positive drug test to prove it, Rocker says. The league asked him to take drug tests after the infamous Sports Illustrated article, he did and in his own words he “failed miserably.” Neyer has some very apt words about what that all means. Basically: Selig was willingly blind to PEDs for years beyond the P.R. implications of it all. It’s undeniable and has been for some time.
Look, I’m the first one to criticize anyone who plays the “of course he was on steroids! Just look at him!” card. But in Rocker’s case? Dudes, really.
Free agent middle infielder Danny Espinosa signed a minor-league deal with the Blue Jays, the team announced Saturday. The deal includes an invite to spring training, where Espinosa is scheduled for his first split-squad game against the Orioles this afternoon.
Espinosa, 30, was inked to another minor-league deal with the Yankees in January. The veteran infielder was competing for an infield job until the team picked up second baseman Neil Walker on a one-year, $4 million deal last Monday. Prior to his release, he slashed .160/.276/.320 with one home run through his first 12 games with the Yankees this spring. He didn’t fare much better in the majors last year, either, batting a cumulative .173/.245/.278 with six home runs and a .523 OPS in 295 PA for the Mariners and Rays.
Blue Jays starting shortstop Troy Tulowitzki is still dealing with a bone spur in his heel and has officially been ruled out for Opening Day, which could clear a path for Espinosa to claim a starting role in Toronto. Of course, he won’t be the only candidate under consideration — Yangervis Solarte and Aledmys Diaz are still in the mix as well, though no final decision appears to be made just yet.